Fig. 3From: Organ specific responses to first-line lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a retrospective analysisPaired intrahepatic tumor and MVTT responses following treatment with lenvatinib plus anti-PD-1 antibodies. a INV assessment; b IIR assessment. MVTT, macrovascular tumor thrombiBack to article page